II Robert C. Goeltz - 23 Jan 2024 Form 4/A Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Chief Financial Officer
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol
RCUS
Transactions as of
23 Jan 2024
Net transactions value
$0
Form type
4/A
Filing time
23 Feb 2024, 17:49:44 UTC
Date Of Original Report
25 Jan 2024
Previous filing
04 Jan 2024
Next filing
17 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Award $0 +22,000 +42% $0.000000 73,831 23 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company.

Remarks:

This amendment is being filed to address an error in reporting the number of restricted stock units granted to Mr. Goeltz on January 23, 2024.